Gilead Sciences (GILD, $67.08) was a top loser over the last three months, falling -1 to $67.08 per share. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry for the 3-month period ending April 24, 2024, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.